Theodore R. Schroeder - 31 May 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
Chief Executive Officer, Director
Signature
/s/ Robert Crotty, by power of attorney
Issuer symbol
NBRVF
Transactions as of
31 May 2021
Transactions value $
-$148
Form type
4
Filing time
02 Jun 2021, 16:12:10 UTC
Previous filing
10 May 2021
Next filing
08 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability -$148 -107 -0.06% $1.38 178K 31 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.